Literature DB >> 11950915

Comparison of multiparameter flow cytometry with cluster analysis and immunohistochemistry for the detection of CD10 in diffuse large B-Cell lymphomas.

Yin Xu1, Robert W McKenna, Steven H Kroft.   

Abstract

CD10 is a critical antigen for the distinction of follicle-center lymphoma from other B-cell lymphomas composed of small cells in fine-needle aspiration specimens, tissue core biopsies, and bone marrow. In addition, CD10 is expressed in a subset of diffuse large B-cell lymphomas (DLBCLs), where it may be an adverse prognostic indicator. We have previously demonstrated that CD10 expression detected by multiparameter flow cytometry (FC) with cluster analysis is highly sensitive and specific for follicle-center lymphoma in the differential diagnosis of small B-cell lymphomas. In this study, we assessed the utility of paraffin section immunohistochemistry (IHC) for CD10 compared with FC in a cohort of 50 DLBCLs. IHC for CD10 was technically successful in 47 of the 50 (94%) DLBCLs; 3 failed based on lack of internal CD10 reactivity. CD10 was expressed by FC in 20 of 47 DLBCLs (43%); CD10 was positive by IHC in 15 of these (75%). All 27 cases that were CD10(-) by FC were negative by IHC. The level of CD10 expression by FC in the 5 FC(+)/IHC(-) cases ranged from relatively dim to bright. Our results indicate 75% sensitivity and 100% specificity of CD10 expression by IHC compared with multiparameter FC with cluster analysis and a 6% technical failure rate.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11950915     DOI: 10.1038/modpathol.3880539

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  8 in total

Review 1.  CD10 expression in diffuse large B-cell lymphomas does not influence survival.

Authors:  Bettina Fabiani; Alain Delmer; Eric Lepage; Catherine Guettier; Tony Petrella; Josette Brière; Anne-Marie Penny; Marie-Christine Copin; Jacques Diebold; Felix Reyes; Philippe Gaulard; Thierry J Molina
Journal:  Virchows Arch       Date:  2004-10-27       Impact factor: 4.064

2.  Bone marrow aspirate and biopsy: a pathologist's perspective. II. interpretation of the bone marrow aspirate and biopsy.

Authors:  Roger S Riley; David Williams; Micaela Ross; Shawn Zhao; Alden Chesney; Bradly D Clark; Jonathan M Ben-Ezra
Journal:  J Clin Lab Anal       Date:  2009       Impact factor: 2.352

3.  A unique bone marrow lymphoma patient presenting with an isolated mass: A case report.

Authors:  Yi-Wen Xu; Ming-Hui Duan
Journal:  Oncol Lett       Date:  2017-12-06       Impact factor: 2.967

4.  CD10 expression in epithelial and stromal cells of non-small cell lung carcinoma (NSCLC): a clinic and pathologic correlation.

Authors:  Duygu Gürel; Aydanur Kargı; Ilgın Karaman; Ahmet Onen; Mehtat Unlü
Journal:  Pathol Oncol Res       Date:  2011-06-18       Impact factor: 3.201

5.  Prognostic evaluation of nodal diffuse large B cell lymphoma by immunohistochemical profiles with emphasis on CD138 expression as a poor prognostic factor.

Authors:  Young-Ha Oh; Chan-Kum Park
Journal:  J Korean Med Sci       Date:  2006-06       Impact factor: 2.153

6.  CD10 and osteopontin expression in dentigerous cyst and ameloblastoma.

Authors:  Shaimaa M Masloub; Adel M Abdel-Azim; Ehab S Abd Elhamid
Journal:  Diagn Pathol       Date:  2011-05-24       Impact factor: 2.644

7.  Primary maxillofacial large B-cell lymphoma in immunocompetent patients: report of 5 cases.

Authors:  Ines Velez; Maritzabel Hogge
Journal:  Case Rep Radiol       Date:  2011-08-24

8.  Immunohistochemistry for CCR4 C-terminus predicts CCR4 mutations and mogamulizumab efficacy in adult T-cell leukemia/lymphoma.

Authors:  Keiichiro Fujii; Yuma Sakamoto; Ayako Masaki; Takayuki Murase; Yukie Tashiro; Kentaro Yonekura; Atae Utsunomiya; Asahi Ito; Shigeru Kusumoto; Shinsuke Iida; Ryuzo Ueda; Takashi Ishida; Hiroshi Inagaki
Journal:  J Pathol Clin Res       Date:  2020-10-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.